---
title: CDMOs offering Bioconjugation Services with Biologics (Other)
path: /explore/bioconjugation/biologics-other
companies_count: 11
---

# CDMOs offering Bioconjugation Services with Biologics (Other)

11 published CDMOs match Bioconjugation Services and Biologics (Other).

Locations in this set include United States, China, United Kingdom, Canada, Estonia, and Germany.

Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Recombinant Protein Manufacturing, ADC (Antibody-Drug Conjugate) Manufacturing, and Biologics Development & Manufacturing.

## Matching companies

- [Abzena](/companies/abzena)
  - Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.
- [Altruist Biologics](/companies/altruist-biologics)
  - Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.
- [GBI Biomanufacturing](/companies/gbi-biomanufacturing)
  - Full-service biologics CDMO offering integrated development and manufacturing services including cell banking, upstream/downstream processing, bioconjugation, aseptic fill-finish, and regulatory support for complex biopharmaceuticals.
- [Gannet Biochem](/companies/gannetbiochem)
  - Gannet BioChem is a specialized CDMO focused on activated polymer, PEG, and bioconjugation services for complex therapeutics, from early development through cGMP manufacturing. It operates facilities in Huntsville and Arab, Alabama.
- [Icosagen](/companies/icosagen)
  - Icosagen is an integrated CRDMO (Contract Research, Development & Manufacturing Organization) specializing in antibody discovery, protein production, cell line development, and GMP manufacturing for biologics programs from discovery through commercial scale.
- [National Resilience](/companies/resilience)
  - End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions)
  - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [Simtra BioPharma Solutions](/companies/simtra-biopharma-solutions)
  - Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.